Genes that Boost Good Cholesterol may Protect Against Heart Disease
News Jun 23, 2008
More than one in three people have genetic variations which raise ‘good cholesterol’ and may protect against heart disease, according to research published by scientists at Cambridge University. The research was funded by the British Heart Foundation (BHF).
Led by Mr. Alexander Thompson and Professor John Danesh, and published in the Journal of the American Medical Association (JAMA), the research used data from 102 different studies and up to 147,000 people from across the world.
The Cambridge team studied genetic variations which affect a protein called cholesteryl ester transfer protein (CETP) which is involved in metabolism of ‘good’ or high-density lipoprotein (HDL) cholesterol. They considered six different variations of the CETP gene that people carried, and looked at the impact the variations had on cholesterol levels and heart disease.
Results showed all three of the most common CETP genetic variations increased ‘good’, HDL cholesterol levels by 3-5%, and people carrying these were about 5% less likely to suffer a heart attack.
With around 227,000 people in the UK suffering a heart attack each year, attempts to prevent heart attacks have previously focused on reducing levels of ‘harmful’ or low-density lipoprotein (LDL) cholesterol with lifestyle improvements and statins (cholesterol drugs). This research suggests that modification of HDL cholesterol could also have benefits, despite previous clinical trials having been unsuccessful.
Professor John Danesh said: “Our genetic findings strengthen the case for further studies to prevent heart disease by raising levels of ‘good’ cholesterol, including by blocking CETP.”
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.